Awareness and Impact of Chronic Obstruct Pulmonary Diseases (COPDs) Asthma on the Global Economy

Abstract

Majority of Africans knows that Asthma is hereditarily caused. Developing Asthma at a later stage in life is spiritually caused and are not aware of the environmental and lifestyle as causes of Asthma. In 2016, the Global Burden of Disease collaboration estimated that 420,000 people in the world died from asthma – more than 1000 per day. International mortality statistics for asthma are limited to those countries reporting detailed causes of death exceeding the death rate of any pandemic globally in a single year.  Over 330 million individuals in the world have asthma, with future increases expected. Not only is the prevalence of asthma increasing, but per-patient costs also appear to be on the rise. Developing countries are facing an even steeper increase in the future burden of asthma, and patients often do not have reliable access to the essential asthma medicines. Chronic Obstruct Pulmonary Diseases such as Asthma is gradually becoming a thorn in the flesh of the world economies. It is not only reducing the productive hours of the active labour force, but is equally draining the gains made by the individuals who have it.